Synchronized Nasal Intermittent Positive Pressure Ventilation versus Nasal Continuous Positive Airway Pressure for Prevention of Extubation Failure in Infants after Congenital Heart Surgery
Prevention of Extubation Failure in Infants After Congenital Heart Surgery
Keywords:SNIPPV, NCPAP, Congenital heart surgery, Cardiopulmonary bypass, Postoperative care
Objective: This study aimed to evaluate the application of synchronized nasal intermittent positive pressure ventilation (SNIPPV) in the respiratory weaning of infants after congenital heart surgery.
Methods: We retrospectively analyzed the clinical data of 63 infants who were extubated from mechanical ventilation after congenital heart surgery between January 2020 and September 2020. The data, including demographics, anatomic diagnosis, radiology and laboratory test results, and perioperative variables were recorded. Results: The extubation failure rate within 48 h after extubation was significantly lower in the SNIPPV group than in the nasal continuous positive airway pressure (NCPAP) group. The PaO2 level and PaO2/FiO2 ratio within 48 h after extubation were higher in the SNIPPV group than in the NCPAP group (P < .05). Meanwhile, the PaCO2 level within 48 h was significantly lower in the SNIPPV group (P < .05). Compared with the NCPAP group, the median duration of postoperative noninvasive support and the duration from extubation to hospital discharge were shorter in the SNIPPV group; the total hospital cost was lower in the SNIPPV group. No significant differences were observed between the two groups concerning VAP, pneumothorax, feeding intolerance, sepsis, mortality, and other complications (P > .05).
Conclusion: SNIPPV was shown to be superior to NCPAP in avoiding reintubation after congenital heart surgery in infants and significantly improved oxygenation and reduced PaCO2 retention after extubation. Further studies are needed to confirm the efficacy and safety of SNIPPV as a routine weaning strategy.
Aghai ZH, Saslow JG, Nakhla T, et al. 2010. Synchronized nasal intermittent positive pressure ventilation (SNIPPV) decreases work of breathing (WOB) in premature infants with respiratory distress syndrome (RDS) compared to nasal continuous positive airway pressure (NCPAP). Pediatr Pulmonol 41:875-81.
Badesch DB, Champion HC, Sanchez MA, et al. 2009. Diagnosis and Assessment of Pulmonary Arterial Hypertension. J Am Coll Cardiol 54(1 Suppl):S55-S66.
Barrington KJ, Bull D, Finer NN. 2001. Randomized trial of nasal synchronized intermittent mandatory ventilation compared with continuous positive airway pressure after extubation of very low birth weight infants. Pediatrics 107:638-41.
Benneyworth BD, Mastropietro CW, Graham EM, et al. 2017. Variation in extubation failure rates after neonatal congenital heart surgery across Pediatric Cardiac Critical Care Consortium hospitals. J Thorac Cardiovasc Surg 153:1519-26.
Bhandari V, Gavino RG, Nedrelow JH, et al. 2007. A randomized controlled trial of synchronized nasal intermittent positive pressure ventilation in RDS. J Perinatol 27:697-703.
Bhandari V. 2010. Nasal intermittent positive pressure ventilation in the newborn: review of literature and evidence-based guidelines. J Perinatol 30:505-12.
Chang HY, Claure N, D'ugard C, et al. 2011. Effects of synchronization during nasal ventilation in clinically stable preterm infants. Pediatr Res 69:84-9.
Chen L, Wang L, Ma J, et al. 2019. Nasal high-frequency oscillatory ventilation in preterm infants with respiratory distress syndrome and ARDS after extubation: A Randomized Controlled Trial. Chest 155:740-8.
Essouri S, Durand P, Chevret L, et al. 2005. Non invasive positive pressure ventilation (NIPPV) in PICU: a promising approach of respiratory support. Pediatric Critical Care Medicine 6:245.
Fedor KL. 2017. Noninvasive respiratory support in infants and children. Respiratory Care 62:699-717.
Gaies M, Tabbutt S, Schwartz SM, et al. 2015. Clinical epidemiology of extubation failure in the pediatric cardiac ICU: A report rrom the Pediatric Cardiac Critical Care Consortium. Pediatr Crit Care Med 16:837-45.
Gaies MG, Gurney JG, Yen AH, et al. 2010. Vasoactive-inotropic score as a predictor of morbidity and mortality in infants after cardiopulmonary bypass. Pediatr Crit Care Med 11:234-8.
Harris KC, Holowachuk S, Pitfield S, et al. 2014. Should early extubation be the goal for children after congenital cardiac surgery? J Thorac Cardiovasc Surg 148:2642-7.
Jasani B, Nanavati R, Kabra N, et al. 2015. Comparison of non-synchronized nasal intermittent positive pressure ventilation versus nasal continuous positive airway pressure as post-extubation respiratory support in preterm infants with respiratory distress syndrome: a randomized controlled trial. J Matern Fetal Neonatal Med 29:1546-51.
Kahramaner Z, Erdemir A, Turkoglu E, et al. 2014. Unsynchronized nasal intermittent positive pressure versus nasal continuous positive airway pressure in preterm infants after extubation. J Matern Fetal Neonatal Med 27:926-9.
Khalaf MN, Brodsky N, Hurley J, et al. 2001. A prospective randomized, controlled trial comparing synchronized nasal intermittent positive pressure ventilation versus nasal continuous positive airway pressure as modes of extubation. Pediatrics 108:13-17.
Lemyre B, Davis PG, De Paoli AG, et al. 2017. Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (NCPAP) for preterm neonates after extubation. Cochrane Database Syst Rev 2:CD003212.
Lu C, Wei J, Cai B, et al. 2020. Etiology and risk factors for extubation failure in low birth weight infants undergoing congenital heart surgery. J Cardiothorac Vasc Anesth 34:3361-6.
Parashar N, Amidon M, Milad A, et al. 2019. Noninvasive neurally adjusted ventilatory assist versus high flow cannula support after congenital heart surgery. World J Pediatr Congenit Heart Surg 10:565-71.
Polin RA, Sahni R. 2002. Newer experience with CPAP. Semin Neonatol 7:379-89.
Richter RP, Alten JA, King RW, et al. 2019. Positive airway pressure versus high-flow nasal cannula for prevention of extubation failure in infants after congenital heart surgery. Pediatr Crit Care Med 20:149-57.
Sai Sunil Kishore M, Dutta S, et al. 2009. Early nasal intermittent positive pressure ventilation versus continuous positive airway pressure for respiratory distress syndrome. Acta Paediatr 98:1412-5.
Tao HF, Tao M, Cai N, et al. 2016. Apllication of nasal synchronous intermittent mandatory ventilation in premature infants with severe respiratory distress syndrome after extubation. Zhongguo Dang Dai Er Ke Za Zhi 18:1-5.
Zhou B, Zhai JF, Jiang HX, et al. 2015. Usefulness of DuoPAP in the treatment of very low birth weight preterm infants with neonatal respiratory distress syndrome. Eur Rev Med Pharmacol Sci 19:573-7.
How to Cite
Author Disclosure & Copyright Transfer Agreement
In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.
A current form follows:
The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.
However, Publisher grants back to the author(s) the following:
- The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
- The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
- The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
- The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
- The right to make oral presentations of material from this work.
Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.
I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.
I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).
I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.
Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).